INSM
Insmed Incorporated
Stock
$111.12+2.53 (+2.33%)Close Oct 2, 2026
- Stock-based compensation, 2025
- $153M
- YoY, 2025
- +57.7%
- 5-year CAGR
- +33.4%
- 10-year CAGR
- +25.6%
Stock-based compensation
Stock-based compensation by fiscal year
| Period | Stock comp | YoY |
|---|---|---|
| 2025 | $153M | +57.7% |
| 2024 | $97M | +29.5% |
| 2023 | $75M | +29.6% |
| 2022 | $58M | +25.3% |
| 2021 | $46M | +27.3% |
| 2020 | $36M | +34.1% |
| 2019 | $27M | +2.8% |
| 2018 | $26M | +45.2% |
| 2017 | $18M | +0.2% |
| 2016 | $18M | +15.7% |
| 2015 | $16M | +37.6% |
| 2014 | $11M | +30.7% |
| 2013 | $8.7M | +190.8% |
| 2012 | $3.0M | +86.4% |
| 2011 | $1.6M | +336.9% |
| 2010 | $366K | −85.6% |
| 2009 | $2.5M | — |